This hypothesis was confirmed by Ferreira et al. who showed that ibuprofen, an inhibitor of prostaglandin E2 and COX-2, which belongs to the non-steroidal anti-inflammatory drugs (NSAIDs) group, strongly synergizes with PD-1 therapy in a treatment of murine model of melanoma [76]. Here, PTGS2 is linked to melanoma.